66 -12 (62) 2023 — G.U. Khudoibergenov — PATHOMORPHOLOGICAL CHANGES IN THE VASCULAR COAT OF THE EYEBALL IN CAVERNOUS SINUS THROMBOSIS AS A COMPLICATION OF COVID-19

PATHOMORPHOLOGICAL CHANGES IN THE VASCULAR COAT OF THE EYEBALL IN CAVERNOUS SINUS THROMBOSIS AS A COMPLICATION OF COVID-19

G.U. Khudoibergenov  Tashkent Medical Academy

Resume

The aim of this study was to investigate the features of the inflammatory and necrotic processes in the tissues of the vascular coat of the eyeball (iris, ciliary body, and choroid) in patients with cavernous sinus thrombosis associated with COVID-19. It was found that SARS-CoV-2 infection leads to thrombosis of the cavernous sinus of the brain in the veins of the vascular coat of the eyeball, accompanied by pronounced circulatory disturbances, edema, and necrobiosis in all layers, along with lymphoproliferative inflammation in the interstitial layer. Due to the relatively pronounced development of circulatory changes in the ciliary body, which is a continuation of the vascular coat, the appearance of massive hemorrhages and tissue necrosis was observed.

Keywords: COVID-19; cavernous sinus thrombosis; vascular coat of the eyeball; pathomorphology.

First page

382

Last page

388

For citation: G.U. Khudoibergenov – PATHOMORPHOLOGICAL CHANGES IN THE VASCULAR COAT OF THE EYEBALL IN CAVERNOUS SINUS THROMBOSIS AS A COMPLICATION OF COVID-19 //New Day in Medicine 2023 12(62): 382-388 https://newdaymedicine.com/index.php/2023/12/26/l-667/

LIST OF REFERENCES:

1. Gupta A., Dixit B., Stamoulas K., Akshikar R. Atypical bilateral acute retinal necrosis in a coronavirus disease 2019 positive immunosuppressed patient. // Eur J Ophthalmol. – 2020.
2. Grajewski R.S., Rokohl A.C., Becker M. A missing link between SARS-CoV-2 and the eye? ACE2 expression on the ocular surface. // J Med Virol. – 2020.
3. Honavar S.G. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. // Indian J Ophthalmol. – 2021;69(6):1361-1365.
4. Hwang J., Hong H.S. Fulminant superior ophthalmic vein thrombosis and cavernous sinus thrombophlebitis with intracranial extensions: case reports // J. Korean Soc. Ther. Radiol. Oncol. – 2015;72(6):418-422.
5. Jianzeng Dong, Zhen Ghong Yuan, Zhongren Ding, Yi Zhang SARS-CoV-2 activation of ACE2 platelets, increasing thrombosis in COVID-19 // J Hematol Oncol.  2020;13:120.
6. Ibrahim A.S., Spellberg B., Walsh T.J., Kontoyiannis D.P. Pathogenesis of mucormycosis. // Clin Infect Dis. 2012;54(Suppl 1):16-22.
7. Klok F.A., Kruip M., van der Meer N.J.M. The rate of thrombotic complications in patients with COVID-19. // ThrombRes. – 2020.
8. Lauande R., Paula J.S. Coronavirus and the eye: what is relevant so far? // Arq Bras Oftalmol. – 2020;83(3).
9. Leisman D.E., Deutschman C.S., Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. // Intensive Care Med. – 2020.
10. Matthew T.J.H., Hussein A., Atypical cavernous sinus thrombosis: a diagnosis challenge and dilemma // Cureus. 2018;10(12).
11. Ortiz-Seller A., Martínez Costa L., Hernández-Pons A. Ophthalmic and neuro-ophthalmic manifestations of coronavirus disease 2019 (COVID-19) // Ocul Immunol Inflamm. 2020;28:1285-1289. 
12. Plewa M.C., Tadi P., Gupta M., Cavernous Sinus Thrombosis // StatPearls Publishing, StatPearls. Treasure Island (FL). – 2019.